Table 2 Baseline characteristics of HIV infected children in HIV clinic at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia from April 1 to May 15, 2018 (n = 318).Baseline characteristics of
Variables | N (%) |
|---|---|
Age years (at the time of cART initiation) | |
  ≤ 11 months | 91(28.6) |
 12 to 34 months | 63(19.8) |
 35–59 months | 52(16.4) |
  ≥ 60 months | 112(35.2) |
Initial HAART Regimen | |
 D4T-3TC-NVP | 59(18.5) |
 D4T-3TC-EFV | 17(5.3) |
 AZT-3TC-NVP | 103(32.3) |
 AZT-3TC-EFV | 53(16.6) |
 TDF-3TC-EFV | 26(8.1) |
 AZT-3TC-LPV/r | 10(3.1) |
 ABC-3TC-LPV/r | 6(1.5) |
 ABC-3TC-EFV | 23(7.2) |
 D4T-3TC-LPV/r | 21(6.6) |
Initial cART dosing preparations | |
 One loose | 94(29.6) |
 Three loose | 81(25.5) |
 Fixed | 143(45) |
PMTCT Service | |
 Present | 21(6.6) |
 None | 237(74.5) |
 Unknown | 60(18.8) |
Infant ART Prophylaxis | |
 Yes | 37(11.6) |
 No | 235(73.8) |
 Unknown | 56(17.6) |
Baseline Immunosuppression level | |
 Not Significant Immunosuppression (≥  500 or > 25%) | 3(0.94) |
 Mild Immunosuppression (350–499 or 20–24%) | 23(7.2) |
 Advanced Immunosuppression (200–349 or 15–19%) | 137(43.08) |
 Severe Immunosuppression (< 200 or < 15%) | 155(48.74) |
Base line WHO staging | |
 Stage 1 | 26(8.17) |
 Stage 2 | 109(34.3) |
 Stage 3 | 155(48.7) |
 Stage 4 | 28(8.8) |